Alembic Pharma gets USFDA nod for Fulvestrant injection, 250 mg/5 mL per single-dose syringe EP News Bureau Dec 26, 2022 Fulvestrant injection is an estrogen receptor antagonist indicated for the treatment of breast cancer
Dr Reddy’s Laboratories launches Fulvestrant Injection in US EP News Bureau Sep 7, 2020 Fulvestrant is an estrogen receptor antagonist indicated for the treatment of HR-positive advanced breast cancer
